Saturday, September 14, 2024 4:17:24 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent IMVT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:33:01 PM
- Immunovant Announces Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED) • GlobeNewswire Inc. • 04/02/2026 09:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:07:42 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/10/2026 10:16:55 PM
- Immunovant shares climb 7% as fiscal Q3 loss comes in better than expected • IH Market News • 02/06/2026 03:50:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/06/2026 12:24:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2026 12:16:39 PM
- Immunovant Provides Corporate Updates and Reports Financial Results for the Third Quarter Ended December 31, 2025 • GlobeNewswire Inc. • 02/06/2026 12:00:00 PM
- Immunovant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026 • GlobeNewswire Inc. • 01/23/2026 10:25:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2025 09:15:25 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/12/2025 11:01:56 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2025 11:39:33 AM
- Immunovant Announces Pricing of $550 Million Common Stock Financing • GlobeNewswire Inc. • 12/11/2025 06:29:26 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/26/2025 10:07:57 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/26/2025 12:16:56 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 09:24:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2025 01:00:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/10/2025 12:30:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 12:15:38 PM
- Immunovant Provides Corporate Updates and Reports Financial Results for the Second Quarter Ended September 30, 2025 • GlobeNewswire Inc. • 11/10/2025 12:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/05/2025 04:35:23 PM
- Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025 • GlobeNewswire Inc. • 10/27/2025 08:10:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/24/2025 08:38:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/10/2025 08:03:10 PM

